Conjunctival fibrosis remains the major impediment to the success of glaucoma filtration
surgery. Anti-metabolites remain the gold standard for mitigating post-surgical fibrosis, but …

Ocular drug delivery is a challenging but fascinating topical route of administration. Although
the eye is easily accessible to common drug formulations such as drops, its complex …

Most common intraocular pressure (IOP) reduction regimens for the management of
glaucoma include the topical use of eye drops, a dosage form that is associated with short …

Glaucoma is a progressive optic neuropathy in the eye, which is a leading cause of
irreversible blindness worldwide and currently affects over 70 million individuals. Clinically …

Biomaterials are implanted in millions of individuals worldwide each year. Both naturally
derived and synthetic biomaterials induce a foreign body reaction that often culminates in …

To evaluate the effectiveness and biocompatibility of Wistend, a novel Schlemm's canal (SC)
microstent made of Nitinol designed to improve aqueous humor outflow. New Zealand white …

Glaucoma drainage devices are implanted in the eye to treat glaucoma, a disease that can
cause vision loss and blindness. These devices are designed to reduce intraocular pressure …

This review is devoted to the development of a technique for the fabrication of tubular
samples based on needleless electrospinning. Such materials have the potential for use in a …

青光眼是导致视力丧失的主要原因之一, 其诊疗仍存在诸多困难, 如持续眼压监测,
抗青光眼药物制剂的副作用和长期应用以及引流物植入术后的并发症等. 纳米材料因其具有尺寸 …

Primary congenital glaucoma (PCG) is an ocular disease characterized by congenital
anterior segmental maldevelopment with progressive optic nerve degeneration. Certain …